selected publications
-
article
- American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care and Research. 71:579-590. 2019-01-01
- Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies [Tofacitinib, un inhibidor oral de la cinasa Janus, en pacientes Mexicanos con Artritis Reumatoide: análisis de eficacia y seguridad de estudios fase 3 y de extensión a largo plazo]. Reumatologia Clinica. 15:43-53. 2019-01-01
- Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years. Arthritis %26 rheumatology (Hoboken, N.J.). 67:2759-2770. 2015-01-01
- Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology. 39:50-57. 2010-01-01
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis and Rheumatism. 62:1792-1802. 2010-01-01
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. The Lancet. 372:383-391. 2008-01-01
- Guidelines for the treatment of ankylosing spndylitis and its effect in Mexican rheumatology [Fundamentos para el tratamiento de la espondilitis anquilosante y su efecto en la reumatología mexicana]. Gaceta Medica de Mexico. 41-49. 2009-01-01
- Guidelines in RA treatment: Concepts on safety and recomendations using anti-TNF-α inhibitors [Recomendaciones para el tratamiento médico de la artritis reumatoide: Actualización sobre la seguridad de los antagonistas del factor de necrosis tumoral alfa]. Revista de Investigacion Clinica. 252-266. 2009-01-01